Achieve life sciences to present at the barclays 27th annual global healthcare conference

Seattle and vancouver, british columbia, march 07, 2025 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will be presenting at the barclays 27th annual global healthcare conference to be held march 11-13, 2025, in miami, fl.
ACHV Ratings Summary
ACHV Quant Ranking